LeMaitre Vascular Beheer
Beheer criteriumcontroles 4/4
De CEO LeMaitre Vascular is George LeMaitre, benoemd in Jun1992, heeft een ambtstermijn van 32.42 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 2.22M, bestaande uit 26.7% salaris en 73.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 8.32% van de aandelen van het bedrijf, ter waarde $ 197.30M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 14.6 jaar en 19 jaar.
Belangrijke informatie
George LeMaitre
Algemeen directeur
US$2.2m
Totale compensatie
| Percentage CEO-salaris | 26.7% |
| Dienstverband CEO | 32.4yrs |
| Eigendom CEO | 8.3% |
| Management gemiddelde ambtstermijn | 14.6yrs |
| Gemiddelde ambtstermijn bestuur | 19yrs |
Recente managementupdates
Recent updates
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 26% Price Boost Is Out Of Tune With Earnings
Nov 24
LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
Nov 03LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 02Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?
Oct 08Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)
Sep 17LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings
Sep 04If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity
Aug 22LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Jul 23Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?
Jul 12Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Jun 18Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing
Jun 05LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08LeMaitre Vascular goes ex dividend tomorrow
Aug 23Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$41m |
| Jun 30 2024 | n/a | n/a | US$38m |
| Mar 31 2024 | n/a | n/a | US$34m |
| Dec 31 2023 | US$2m | US$593k | US$30m |
| Sep 30 2023 | n/a | n/a | US$27m |
| Jun 30 2023 | n/a | n/a | US$25m |
| Mar 31 2023 | n/a | n/a | US$21m |
| Dec 31 2022 | US$2m | US$568k | US$21m |
| Sep 30 2022 | n/a | n/a | US$21m |
| Jun 30 2022 | n/a | n/a | US$22m |
| Mar 31 2022 | n/a | n/a | US$27m |
| Dec 31 2021 | US$2m | US$473k | US$27m |
| Sep 30 2021 | n/a | n/a | US$28m |
| Jun 30 2021 | n/a | n/a | US$29m |
| Mar 31 2021 | n/a | n/a | US$24m |
| Dec 31 2020 | US$1m | US$311k | US$21m |
| Sep 30 2020 | n/a | n/a | US$19m |
| Jun 30 2020 | n/a | n/a | US$16m |
| Mar 31 2020 | n/a | n/a | US$18m |
| Dec 31 2019 | US$1m | US$438k | US$18m |
| Sep 30 2019 | n/a | n/a | US$19m |
| Jun 30 2019 | n/a | n/a | US$18m |
| Mar 31 2019 | n/a | n/a | US$23m |
| Dec 31 2018 | US$1m | US$438k | US$23m |
| Sep 30 2018 | n/a | n/a | US$21m |
| Jun 30 2018 | n/a | n/a | US$22m |
| Mar 31 2018 | n/a | n/a | US$18m |
| Dec 31 2017 | US$889k | US$162k | US$17m |
Compensatie versus markt: De totale vergoeding ($USD 2.22M ) George } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.42M ).
Compensatie versus inkomsten: De vergoeding van George is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
George LeMaitre (59 yo)
32.4yrs
Tenure
US$2,220,797
Compensatie
Mr. George W. LeMaitre has been Chief Executive Officer of Lemaitre Vascular, Inc. since June 1992 and has been its Chairman since 2004. Mr. LeMaitre served as the President of Lemaitre Vascular from June...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & CEO | 32.4yrs | US$2.22m | 8.32% $ 197.3m | |
| President & Director | 17.3yrs | US$1.13m | 0.063% $ 1.5m | |
| CFO, Secretary & Director | 17.3yrs | US$1.07m | 0.039% $ 928.7k | |
| Senior Vice President of Operations | 19.8yrs | US$670.38k | 0.0071% $ 167.6k | |
| Founder and Chairman of Scientific Advisory Board | 41.8yrs | US$138.40k | geen gegevens | |
| Vice President of Marketing | 21.8yrs | geen gegevens | geen gegevens | |
| Senior Director of Human Resources | 4.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Information Technology | less than a year | geen gegevens | geen gegevens | |
| Senior Vice President of Sales – Central Europe | less than a year | geen gegevens | geen gegevens | |
| Senior Vice President of Advanced Manufacturing Engineering | 1.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Clinical | 11.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of EMEA Operations | 4.1yrs | geen gegevens | geen gegevens |
14.6yrs
Gemiddelde duur
50.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van LMAT is doorgewinterd en ervaren (gemiddelde ambtstermijn van 14.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & CEO | 32.4yrs | US$2.22m | 8.32% $ 197.3m | |
| President & Director | 23.5yrs | US$1.13m | 0.063% $ 1.5m | |
| CFO, Secretary & Director | 8.1yrs | US$1.07m | 0.039% $ 928.7k | |
| Founder and Chairman of Scientific Advisory Board | no data | US$138.40k | geen gegevens | |
| Independent Director | 21.8yrs | US$153.50k | 0.017% $ 391.3k | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 16.2yrs | US$163.00k | 0.21% $ 5.1m | |
| Independent Director | 4.6yrs | US$144.50k | 0.0052% $ 124.2k |
19.0yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van LMAT zijn ervaren en ervaren (gemiddelde ambtstermijn van 19 jaar).